DS STAGE II MULTIPLE MYELOMA
Clinical trials for DS STAGE II MULTIPLE MYELOMA explained in plain language.
Never miss a new study
Get alerted when new DS STAGE II MULTIPLE MYELOMA trials appear
Sign up with your email to follow new studies for DS STAGE II MULTIPLE MYELOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise in multiple myeloma battle
Disease control OngoingThis phase 3 trial compares two drug combinations for people with newly diagnosed multiple myeloma who are not planning an immediate stem cell transplant. One group gets lenalidomide plus low-dose dexamethasone, and the other gets those two drugs plus bortezomib. The goal is to s…
Matched conditions: DS STAGE II MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 10:10 UTC
-
Can a pill keep myeloma at bay after transplant? major trial seeks answers
Disease control OngoingThis study looked at whether taking lenalidomide (a drug that helps the immune system fight cancer) after a stem cell transplant can keep multiple myeloma from coming back longer than taking a placebo. About 460 people with active multiple myeloma took part. The goal was to see h…
Matched conditions: DS STAGE II MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 15, 2026 11:57 UTC
-
New combo therapy shows promise in myeloma battle
Disease control OngoingThis study tested two different doses of dexamethasone (a chemotherapy drug) combined with lenalidomide (an immune-boosting drug) in 452 people newly diagnosed with multiple myeloma. The goal was to see which dose worked better at shrinking tumors. If the first combination didn't…
Matched conditions: DS STAGE II MULTIPLE MYELOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 01, 2026 15:58 UTC